Sascan Meditech Pvt. Ltd.

Sascan Meditech Pvt. Ltd. specializes in advanced cancer screening technologies, focused on the early detection of malignant lesions using innovative optical imaging devices. Founded in 2015 in Thiruvananthapuram, India, Sascan Meditech Pvt.

Ltd. develops medical devices for cancer diagnosis. The company has attracted INR 10. 000 mn in funding from Unicorn India Ventures in April 2021, marking a significant investment in its growth strategy.

Subhash Narayanan and Usha Subhash co-founded the company, with Subhash Narayanan serving as the CEO. Sascan Meditech Pvt. Ltd. specializes in advanced cancer screening technology through its flagship product, the OralScan device.

This device utilizes multispectral imaging to detect potentially malignant lesions, focusing on squamous cell carcinoma. The company's product suite also includes the CerviScan device and a range of health products designed to enhance diagnostic accuracy and minimize invasive procedures. Their primary customers are healthcare providers, clinics, and hospitals across India and other regions where cancer detection is crucial. In the most recent fiscal year 2024, Sascan Meditech reported revenue of INR 121,537.

3 mn and an EBITDA of INR -20,733. 4 mn, reflecting their operational performance in the medical device sector. Sascan Meditech is actively working on further developing its product line, including advancements in the OralScan device and the anticipated launch of new technologies aimed at improving cancer diagnostics. The company is also exploring expansion into international markets, with plans to broaden its reach in Southeast Asia by 2023.

The recent funding of INR 10. 000 mn is expected to support these initiatives, further strengthening their capabilities in cancer detection and diagnostics.